about
Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen.Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study.Axis II comorbidity in euthymic bipolar disorder patients: no differences between bipolar I and II subtypes.Clinical predictors of health-related quality of life in obsessive-compulsive disorder.Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions.Obsessive-compulsive disorder and cyclothymic temperament: an exploration of clinical features.Early-onset obsessive-compulsive disorder and personality disorders in adulthood.Bipolar obsessive-compulsive disorder and personality disorders.Personality disorders in patients with burning mouth syndrome.DSM-IV obsessive-compulsive personality disorder: prevalence in patients with anxiety disorders and in healthy comparison subjects.Occurrence and clinical correlates of psychiatric co-morbidity in delusional disorder.Weight Gain During Long-Term Treatment of Obsessive-Compulsive DisorderTransient acute depressive state induced by subthalamic region stimulation.Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/deliveryGender-related clinical differences in obsessive-compulsive disorderAn exploratory study on obsessive-compulsive disorder with and without a familial component: are there any phenomenological differences?Bulimia nervosa with and without obsessive-compulsive syndromesValproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapseImpact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypesAnti-brain antibodies in adult patients with obsessive-compulsive disorderFamily accommodation in obsessive-compulsive disorder: Relation to symptom dimensions, clinical and family characteristicsEffectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter studyVortioxetine treatment-emergent mania in the elderly: a case report
P50
Q34635611-9DCF4602-0E58-49FD-A549-B9C44F4F6207Q35029893-5C9D0628-2943-446E-AA41-80FC0C22CAC9Q42628613-396B995C-6535-44FE-B7E5-E5EBDE0B759AQ44796286-9B52B84F-764C-4F3D-BA5D-1E9E27E25EFFQ45721376-636031A1-1AAC-47CE-894D-0F9D2264D7A9Q48886973-5B70E998-F377-4E17-A6F0-DF57E5E5140AQ51356972-ECBEE6B4-7223-4323-9300-88544ACDC8B4Q51848767-CB65C731-E06A-4281-9AE3-CF57BD0E4B47Q51894385-731BB191-E864-491D-AFF4-03E1ABB11F64Q51897572-9777826B-1781-4053-A37F-4A3B9620D402Q51930001-2473B455-7854-4384-98F8-11A9C4FAEBEFQ51937985-FEB01768-1384-468B-9331-982849DD68A4Q51965861-51FDB6E3-BD99-491D-8282-3F4178EAAEBEQ56138337-F18A5D8A-0510-422A-B918-8530AA8ACD68Q67211410-626F7438-F4CA-49F8-AE2F-4EF5948F35C3Q73375066-9CD1B121-C66D-46EB-B989-AF5087A55419Q73466899-AC2F6559-2DC9-424D-A7AE-09C144CD09CEQ74080958-8C684D79-A070-48DB-B55A-40E3B104CFBEQ77159201-0FB3311B-1E3A-4193-990F-3D26FAA83D3FQ79286377-95D81EEA-2316-4FDA-BFB3-831413CD3D0BQ80581807-1CF80A27-B064-47A2-B453-D136CC7ECD7AQ83177610-3BE5E4A9-5B76-4635-8229-843744D98BBDQ84254376-E738B895-D1DF-4E6D-A138-A72041B41ABAQ84957975-2B1ACB5C-4A37-4730-AC9D-3DE1DE84A1CFQ92067704-94B9CFE9-780C-4F38-8E77-72B786880F84
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Umberto Albert
@ast
Umberto Albert
@en
Umberto Albert
@es
Umberto Albert
@nl
Umberto Albert
@sl
type
label
Umberto Albert
@ast
Umberto Albert
@en
Umberto Albert
@es
Umberto Albert
@nl
Umberto Albert
@sl
prefLabel
Umberto Albert
@ast
Umberto Albert
@en
Umberto Albert
@es
Umberto Albert
@nl
Umberto Albert
@sl
P106
P1153
7003970659
P31
P4012
P496
0000-0001-9781-4219